March—Aegerion Pharmaceuticals (therapeutics for cardiovascular and metabolic diseases) has raised $15mm with the private placement of debt to Hercules Technology Growth Capital.
March—Alacrity Biosciences (vision care pharmaceuticals) has raised $8.45mm by selling convertible notes. Paramount BioSciences acted as the placement agent.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?